| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Oragenics Inc (OGEN) has 7 insiders with recent SEC Form 4 filings, including 0 buys and 13 sells. OGEN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 250.0K | $153.3K | - | |
| Dir | 125.0K | $76.6K | - | |
| Dir | 125.0K | $76.6K | - | |
| Dir | 125.0K | $76.6K | - | |
| Dir | 125.0K | $76.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 12, 2025 | Telling Fred50 | Director | Sell | 210 | $0.94 | $198.37 | -0.6% | +5.0% | - | |
| Dec 6, 2024 | Telling Fred50 | Director | Sell | 3,597 | $0.36 | $1,294.92 | -9.4% | -25.0% | -92.0% | |
| Dec 6, 2024 | Dunton Alan W86 | Director | Sell | 66 | $0.36 | $23.76 | -0.3% | -25.0% | -92.0% | |
| Nov 30, 2023 | Telling Fred50 | Director | Sell | 3,500 | $3.57 | $12,488.35 | -8.4% | -60.3% | -91.1% | |
| Dec 30, 2022 | Koski Robert C71 | Director | Sell | 79,005 | $0.11 | $8,353.35 | -5.8% | -53.7% | -10.8% | |
| Dec 15, 2022 | Koski Robert C71 | Director | Sell | 165,497 | $0.18 | $29,074.37 | -6.4% | -66.1% | -48.4% | |
| Dec 14, 2022 | Koski Robert C71 | Director | Sell | 4,503 | $0.18 | $788.03 | -0.3% | -65.0% | -46.8% | |
| Dec 9, 2022 | Koski Robert C71 | Director | Sell | 48,795 | $0.20 | $9,612.62 | -3.6% | -66.7% | -56.4% | |
| Dec 8, 2022 | Koski Robert C71 | Director | Sell | 13,036 | $0.20 | $2,607.20 | -0.9% | -66.6% | -58.0% | |
| Nov 30, 2022 | Koski Robert C71 | Director | Sell | 400,000 | $0.19 | $76,680.00 | -11.9% | -61.0% | -69.7% |